Latest Breaking News On - பிராங்கோயிஸ் ஜீன் - Page 1 : vimarsana.com
VANCOUVER -- Researchers say a new drug tested at the University of British Columbia is highly effective against multiple COVID-19 variants. They say the experimental drug called N-0385, developed at Universite de Sherbrooke in Quebec, blocks the virus that causes COVID-19 from entering human cells through its preferred entry point. The experimental drug impedes cellular entry of the virus, says Dr. Richard Leduc, project lead at Sherbrooke. “It’s not a treatment, it’s a protector against the virus," Leduc said, which is why they believe it will work against all variants. N-0385 doesn’t combat a specific strain of COVID-19. It's designed to block viruses of all kinds from entering the human cell in the first place.
New-yorkUnited-statesJapanIndiaUnited-kingdomCornell-universityBrazilVancouverBritish-columbiaCanadaSouth-africaSherbrookePremier League extends African partnership with Infront 9 Mar 2021
Now Playing New deal agreed for free-to-air rights across sub-Saharan Africa until the end of the 2024/25 season
Related Articles
The Premier League has prolonged its partnership with Infront, a Wanda Sports Group company, for free-to-air rights (FTA) across sub-Saharan Africa until the end of the 2024/25 season.
Premier League Director of Broadcasting Paul Molnar said: "We have been very impressed with Infront’s approach to bringing the Premier League to a broader audience with free-to-air broadcasters in Sub-Saharan Africa.
"Infront’s excellent service is already producing results as it helps to bring quality broadcast coverage of the Premier League competition to millions of fans in the region.
BeninParisFrance-generalFranceZambiaBotswanaCameroonPaul-molnarJean-francois-jeanneAndreas-kaeshammerWanda-sports-groupSaharan-africa